Close Menu

NEW YORK ─ The US Food and Drug Administration has approved a diagnostic claim for Hologic's HIV-1 viral load monitoring test, the Aptima HIV-1 Quant Dx assay, making it the first dual-claim assay for both diagnosis and viral load monitoring in the US, the firm announced Friday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.